MDxHealth SA Ordinary Shares (MDXH) Dividend History

MDxHealth SA is a medical technology company specializing in the development and commercialization of advanced molecular diagnostic tests for the detection and management of prostate and bladder cancers. Leveraging genomic biomarkers, the company aims to enhance personalized treatment decisions and improve patient outcomes in urology.

Dividend History

MDxHealth SA Ordinary Shares currently does not pay dividends

Company News

  • MDxHealth appointed Michael Holder to its Board of Directors as Audit Committee Chair, replacing Regine Slagmulder. CFO Ron Kalfus is resigning, with Scott McMahan assuming interim CFO responsibilities.

    GlobeNewswire Inc.
    Featured Companies: CTKB
  • MDxHealth SA (NASDAQ: MDXH) reported better-than-expected sales for its fourth quarter on Wednesday. MDxHealth posted quarterly GAAP loss of 39 cents per share, compared to market expectations for a loss of 15 cents per share. The company’s quarterly sales came in at $19.398 million, beating estimates of $18.136 million, according to data from Benzinga Pro. Michael K. McGarrity, CEO of mdxhealth, said: “Our fourth quarter and full year 2023 results reflect our continued commitment to commercial execution and operational discipline that has driven significant gross margin expansion across our business. With each passing quarter, we continue to build on our position ...

    Benzinga
  • Agiliti (AGTI) delivered earnings and revenue surprises of 8.33% and 0%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
Page data last updated 07/23/2025 19:57:54 UTC